| Filling the void
GLP-1 medications like Ozempic, Wegovy, and Zepbound have become one of the biggest pharmaceutical stories of our time. Today, nearly 1 in 8 U.S. adults have used a GLP-1 drug, and the global GLP-1 market is projected to exceed $130 billion by 2035. These drugs are reshaping how Americans manage weight and metabolic health and delivering life-changing outcomes for millions of people like me. And yet, once a patient walks out of the doctor’s office with a prescription in hand, they are largely on their own — which is exactly the moment TikTok fills the void. The gap matters
Most patients see their doctor monthly or bi-monthly at best. For the roughly 11% who get their prescriptions through telemedicine vendors, oversight can be even more sparse. In between appointments, they are managing titration, side effects, appetite changes, nutrition, and day-to-day decisions that can meaningfully affect their outcomes, mostly on their own. That gap matters. Up to 65% of patients discontinue GLP-1 use within the first year, even though these medications can be life-changing when people have the right support. The issue is not just the drug itself. It is everything around it: education, tracking, reassurance, context, and timely guidance. What patients need
GLP-1 patients do not need more noise. They need better support. They need clear information in the right context from sources that are not trying to sell them something misleading. They need a way to track side effects, weight loss, and medication patterns over time. They need tools that help them understand what is happening in their own bodies and have better conversations with their doctors. They also need to understand that titration is not one-size-fits-all. Personalized dosing and informed adjustments are often the difference between the clinical promise of these drugs and what actually happens in real life. Patients should not have to evaluate the motives of a stranger with an affiliate link just to figure out how to manage a medication they are paying hundreds of dollars a month for. They deserve support infrastructure that matches the sophistication of the drugs themselves. They deserve to be treated like active participants in their own care. — By MedCity Influencer Aja Beckett |
No comments